type here...

CATEGORIES

Clinical Trials

LATEST

123Page 1 of 3

TRENDING

EDITORS CHOICE

Colchicine Shows 48% Reduction in Future Cardio Issues for Heart Attack Victims

Medika Life -
Early, in-hospital treatment with colchicine reduces the odds of future cardiovascular problems by 48% in people who have just survived a heart attack

Hepion Pharmaceuticals’ CRV431 Demonstrates Efficacy in Kidney Fibrosis

Medika Life -
CRV431 has exerted antifibrotic activity in a number of in vitro and in vivo studies conducted by independent research laboratories

The Data Are In: Steroids Should Be Standard Of Care For COVID-19

Dr. Hesham A. Hassaballa -
Multiple studies were published in JAMA with respect to steroids and outcomes in COVID-19. The most important one was a meta-analysis, which is a study of multiple randomized trial data

Tech Marches On, While Humanity Drags Its Feet

John Nosta -
I thought it would be fun to look back at some of my predictions for health tech from almost a decade ago in Forbes....

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories